BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 4, 2022
View Archived Issues
The enzyme NOX4 is essential for the antidiabetes effect of exercise
Read More
YAP1 promotes salivary gland regeneration after injury
Read More
Novel inhibitors of fungal FA biosynthesis show broad-spectrum antifungal activity
Read More
Medshine Discovery discloses EZH2 inhibitors
Read More
Leo Pharma patents IL-17 modulators
Read More
Chinese researchers synthesize new SOS1 inhibitors
Read More
Roche identifies new ENPP2 inhibitors
Read More
Arbutus Biopharma presents new HBV and/or HDV capsid assembly inhibitors
Read More
Discovery of triple-action inhibitor for the treatment of neurodegenerative diseases
Read More
uPA-uPAR blockade protects intestinal epithelial barrier from inflammation-induced damage
Read More
Novel allosteric inhibitor of tumor-promoting PPI between AIMP2-DX2 and HSP70
Read More
Ovid licenses KCC2 transporter activators from AstraZeneca
Read More
Jemincare's JMB-2002 retains efficacy against Omicron variant of SARS-CoV-2
Read More
German grant supports Evotec's development of EVT-075 for COVID-19
Read More
Amberstone Biosciences completes financing round to support immuno-oncology pipeline
Read More
PLCbeta4 blockade is a potential approach for treating uveal melanoma
Read More
Ascletis announces new oral direct-acting antivirals being developed for SARS-CoV-2 infection
Read More
Kyverna licenses CAR T construct for use in autologous and allogeneic therapies
Read More
Garvan Institute awarded grant to investigate new treatment approach for pancreatic cancer
Read More